Home

DP VI Associates, L.P.

CIK 1298034 · last filed 2016-05-02

DP VI Associates, L.P. is a corporate insider who has filed 14 SEC Form 4 insider transactions across 6 companies since 2008. The most recent filing shows the insider sold $8.2K of CLCD on May 2, 2016. Across all open-market trades the lifetime net is −$232.3K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $253.2K across reported positions. The firm reports its address in Princeton, NJ. 35 SEC filings were submitted jointly with JAMES C BLAIR.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$253.2K

Companies

6

Total Filings

14

Lifetime Open-Market Net

-$232.3K

Filer Profile

Reported Address
ONE PALMER SQUARE
PRINCETON, NJ 08542
Phone
(609) 683-5656
State of Incorporation
DE
Related Filers
JAMES C BLAIR — 35 joint filings, latest 2017-12-13
BRIAN H DOVEY — 35 joint filings, latest 2017-12-13
JESSE I TREU — 35 joint filings, latest 2017-12-13
NICOLE VITULLO — 35 joint filings, latest 2017-12-13
KATHLEEN K SCHOEMAKER — 29 joint filings, latest 2015-05-11
DOMAIN PARTNERS V LP — same reported address
DP V ASSOCIATES LP — same reported address
Domain Partners VI, L.P. — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CoLucid Pharmaceuticals, Inc. (CLCD) Delisted 10%+ Owner 3,284 — — -$8.2K 1 2016-05-02
SNDX Director 13,925 $18.18 $253.2K $0 1 2016-03-08
Tobira Therapeutics, Inc. (RGDO) Delisted 10%+ Owner 513 — — $0 1 2013-08-28
ALIMERA SCIENCES INC (ALIM) Delisted 10%+ Owner 2,655 $5.54 $14.7K -$99.5K 3 2013-06-18
CADENCE PHARMACEUTICALS INC (CADX) Delisted 10%+ Owner 81,906 — — -$124.6K 6 2013-03-11
ZOGENIX, INC. (ZGNX) Delisted 10%+ Owner 13 $26.68 $347 $0 1 2010-12-01

Recent Filings

14 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2016-05-02 CoLucid Pharmaceuticals, Inc. (CLCD) Delisted Sell (S) −1,175 -$8.2K EDGAR
2016-03-08 SNDX Conv (C) +69,625 $0 EDGAR
2014-03-21 — Disp (D) −78,369 -$1.10M
2013-08-28 Tobira Therapeutics, Inc. (RGDO) Delisted Conv (C) +14,539 $0 EDGAR
2013-06-18 ALIMERA SCIENCES INC (ALIM) Delisted Sell (S) −8,304 -$43.9K EDGAR
2013-03-11 CADENCE PHARMACEUTICALS INC (CADX) Delisted Sell (S) −3,546 -$18.6K EDGAR
2013-02-22 CADENCE PHARMACEUTICALS INC (CADX) Delisted Sell (S) −396 -$2.0K EDGAR
2013-02-05 CADENCE PHARMACEUTICALS INC (CADX) Delisted Sell (S) −1,932 -$9.4K EDGAR
2013-01-28 CADENCE PHARMACEUTICALS INC (CADX) Delisted Sell (S) −9,942 -$54.0K EDGAR
2013-01-24 CADENCE PHARMACEUTICALS INC (CADX) Delisted Sell (S) −8,004 -$40.6K EDGAR
Showing 1–10 of 14
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.